FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

SMSLIFE Share Price Discussion

SMS Lifesciences India Ltd.
NSE: SMSLIFE | BSE: 540679 | ISIN: INE320X01016 | Sector: Pharmaceuticals and health care

SMSLIFE Rating

0/5 (0 Ratings)
SMSLIFE Share Price *
282.8 -5.1 (-1.77%)
* (quote may be delayed)
Find answers to all your questions on live SMSLIFE message board: Is SMSLIFE buy or sell? Should I buy SMSLIFE shares? Why are SMSLIFE shares falling? Should I invest in SMSLIFE stock?

You can also check SMSLIFE share price target recommended by brokerages.

SMSLIFE Discussion Forum

@newsbot • Reputation: 2,292
Ranitidine controversy: Which Indian pharma companies stand to lose?
Moneycontrol
Like
reply
Reply
@manish-HJ4-hF4rN • Reputation: 32

Tomorow update
Like
reply
Reply
@pankaj-rkRZo2hfN • Reputation: 0

Any view on SMS life buy or sell
Like
reply
Reply
  • SMSLIFE - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization166.67
    Enterprise Value204.17
    Price to Earnings17.56
    Price to Book Value1.59
    Return on Capital Employed0.09
    Return on Equity0.07
    Face Value10
    Dividend YieldNA
  • SMSLIFE Share Price - Technicals

    keyboard_arrow_down
    SMSLIFE - 52 Week High₹631.95
    SMSLIFE - 52 Week Low₹226.8
  • SMSLIFE Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Feb 14287.9290281.9285.55
    Feb 13288.8303.5281.15287.9
    Feb 12283290281.1283.65
    Feb 11274290266.5281.1
    Feb 10273.8273.8269.05272.25
  • SMSLIFE Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹273.55
    30 Day Moving Average₹274.01
    50 Day Moving Average₹270.55
    100 Day Moving Average₹276.63
    200 Day Moving Average₹350.43
  • SMSLIFE - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue213.45217.54-0.02
    Operating Profit13.2128.45-0.54
    Profit Before Tax6.418.47-0.65
    Net Income6.512.94-0.5
  • SMSLIFE - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds104.9888.40.19
    Total Liabilities145.7290.140.62
    Total Assets250.7178.540.4
  • SMSLIFE - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.040.07
    Return on Equity0.070.16
    Return on Capital Employed0.09NA
  • SMSLIFE - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in RevenueNA
    3 Year CAGR Growth in Operating ProfitNA
    3 Year CAGR Growth in EBIDTANA
    3 Year CAGR Growth in Net IncomeNA
    3 Yr CAGR Growth - Diluted EPSNA
  • SMSLIFE - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in RevenueNA
    5 Year CAGR Growth in Operating ProfitNA
    5 Year CAGR Growth in EBIDTANA
    5 Year CAGR Growth in Net IncomeNA
    3 Yr CAGR Growth - Diluted EPSNA
  • SMSLIFE - Recent News

    keyboard_arrow_down
    NewsBot
    Sep 30 7:53 PM
    Ranitidine controversy: Which Indian pharma companies stand to lose?
    Moneycontrol
  • SMSLIFE - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.